Dysphagia

Current Treatment Options in Gastroenterology

Volumn 7, Issue 4, 2004, Pages 251-258

  Ferguson, Dawn D F ^a   DeVault, Kenneth R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; NITRATE; PROTON PUMP INHIBITOR; SILDENAFIL; TEGASEROD;

ANAMNESIS; BARIUM ENEMA; DIET THERAPY; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG MECHANISM; DYSPHAGIA; ENDOSCOPIC SURGERY; ESOPHAGEAL DYSPHAGIA; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS MYOTOMY; FLUOROSCOPY; HUMAN; LIFESTYLE; MEDICAL EXAMINATION; NEUROMUSCULAR DISEASE; OROPHARYNGEAL DYSPHAGIA; PATHOLOGICAL ANATOMY; REVIEW; SURGICAL TECHNIQUE; SWALLOWING;

EID: 4344585527     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0010-8     Document Type: Review

References (41)

1. Edwards DA: Discriminative information in the diagnosis of dysphagia. J R Coll Physicians Lond 1975, 9:257-263
2. Stal JM, Gregor JC, Preiksaitis HG, et al.: A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture. Can J Gastroenterol 1998, 12:43-49.
3. Marks RD, Richter JE, Rizzo J, et al.: Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994, 106:907-915.
4. Silvis SE, Farahmand M, Johnson JA, et al.: A randomized, blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis. Gastrointest Endosc 1996, 43:216-221.
5. Triadafilopoulos G, Aaronson M, Sackel S, Burakoff R: Medical treatment of esophageal achalasia: double-blind crossover study with oral nifedipine, verapamil, and placebo. Dig Dis Sci 1991, 36:260-267.
6. Traube M, Dubovik S, Lange RC, et al.: The role of nifedipine therapy in achalasia: results of a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 1989, 84:1259-1262.
7. Chrysos E, Tzovaras G, Epanomeritakis E, et al.: Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux. Aust NZ J Surg 2001, 71:98-102.
8. Hatlebakk J, Castell J, Spiegel J, et al.: Dilatation therapy for dysphagia in patients with upper esophageal sphincter dysfunction: manometric and symptomatic response. Dis Esophagus 1998, 11:254-259.
9. Solt J, Bajor J, Moizs M, et al.: Primary cricopharyngeal dysfunction: treatment with balloon catheter dilatation. Gastrointest Endosc 2001, 54:767-771.
10. Vakil N, Kadakia S, Eckardt VF: Pneumatic dilation in achalasia. Endoscopy 2003, 35:526-530.
11. Kochhar R, Makharia G: Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures. Gastrointest Endosc 2002, 56:829-834.
12. Bhutani MS, Usman N, Shenoy V, et al.: Endoscopic ultrasound miniprobe-guided steroid injection for treatment of refractory esophageal strictures. Endoscopy 1997, 29:757-759.
13. Bekel J, Agrawal S: Empiric esophageal dilatation in patients with dysphagia and normal upper endoscopy. Am J Gastroenterol 2003, 98(suppl):S33-S34.
14. Neuman S: Swallowing therapy with neurologic patients: results of direct and indirect therapy methods in 66 patients suffering from neurological disorders. Dysphagia 1993, 8:150-153.
15. Neumann S, Bartolome G, Buchholz D, et al.: Swallowing therapy of neurologic patients: correlation of outcome with pretreatment variables and therapeutic methods. Dysphagia 1995, 10:1-5.
16. Sudo E, Tnauma S, Higuchi N, et al.: Swallowing rehabilitation in two elderly patients with cerebral infarction. Nippon Ronen Igakkai Zasshi 2001, 38:554-559.
17. Prosiegel M, Heintze M, Wagner-Sonntag E, et al.: Kinematic analysis of laryngeal movements in patients with neurogenic dysphagia before and after swallowing rehabilitation. Dysphagia 2000, 15:173-179.
18. Huckabee ML, Cannito MP: Outcomes of swallowing rehabilitation in chronic brain stem dysphagia: a retrospective evaluation. Dysphagia 1999, 14:93-109.
19. Zuydam AC, Rogers SN, Brown JS, et al.: Swallowing rehabilitation after oro-pharyngeal resection for squamous cell carcinoma. Br J Oral Maxillofac Surg 2000, 38:513-518.
20. Blalock D: Speech rehabilitation after treatment of laryngeal carcinoma. Otolaryngol Clin North Am 1997, 30:179-188.
21. Rademaker AW, Logeman JA, Pauloski BR, et al.: Recovery of postoperative swallowing in patients undergoing partial laryngectomy. Head Neck 1993, 15:325-334.
22. Shikowitz MJ, Levy J, Villano D, et al.: Speech and swallowing rehabilitation following devastating caustic ingestion: techniques and indicators for success. Laryngoscope 1996, 106(suppl 78):1-12.
23. Buchholz DW: Cricopharyngeal myotomy may be effective treatment for selected patients with neurogenic oropharyngeal dysphagia. Dysphagia 1995, 10:255-258.
24. Poirier NC, Bonavina L, Taillefer R, et al.: Cricopharyngeal myotomy for neurogenic oropharyngeal dysphagia. J Thorac Cardiovasc Surg 1997, 113:233-241.
25. Campbell B, Tuominen TC, Toohill RJ: The risk and complications of aspiration following cricopharyngeal myotomy. Am J Med 1997, 103:61S-63S.
26. Pasricha PJ, Ravich WJ, Hendrix TR, et al.: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995, 332:774-778.
27. Cuilliere C, Ducrotte P, Zerbib F, et al.: Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997, 41:87-92.
28. Vaezi MF, Rchter JE, Wilcox CM, et al.: Botulinum toxin versus pneumatic dilation in the treatment of achalasia: a randomized trial. Gut 1999, 44:231-239.
29. Miller LS, Parkman HP, Schiano TD, et al.: Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996, 41:2025-2031.
30. Yokoyama T, Asai M, Kumada M, et al.: Botulinum toxin injection into the cricopharyngeal muscle for dysphagia: report of 2 successful cases. Nippon Jibiinkoka Gakkai Kaiho 2003, 106:754-757.
31. Restivo DA, Marchese Ragona R, Staffieri A, et al.: Successful botulinum toxin treatment of dysphagia in oculopharyngeal muscular dystrophy. Gastroenterology 2000, 119:1416.
32. Kamitsukasa I, Kojima S, Nakajima M, et al.: Botulinum toxin therapy for cricopharyngeal spasm. Rinsho Shinkeigaku-Clinical Neurology 1999, 39:364-366.
33. Haapaniemi JJ, Laurikainen EA, Pulkkinen J, et al.: Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 2001, 16:171-175.
34. DeVault KR: Dysphagia from esophageal diverticulosis responding to botulinum toxin injection. Am J Gastroenterol 1997, 92:895-897.
35. Spinelli P, Ballardini G: Botulinum toxin type A for the treatment of Zenker's diverticulum. Surg Endosc 2003, 17:660.
36. Pototschnig CA, Schneider I, Eckel HE, et al.: Repeatedly successful closure of the larynx for the treatment of chronic aspiration with the use of botulinum toxin A. Ann Otol Rhinol Laryngol 1996, 105:521-524.
37. Schneider I, Thumfart WF, Pototschnig C, Eckel HE: Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new noninvasive method. Ann Otol Rhino Laryngol 1994, 103:31-35.
38. Atkinson SI, Rees J: Botulinum toxin for cricopharngeal dysphagia: case reports of CT-guided injection. J Otolaryngol 1997, 26:273-276.
39. Quintao B, Siqueira ES, Ferrari AP: Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection. Dis Esophagus 1999, 12:68-73.
40. Bortolotti M, Pandolfo N, Giovannini M, et al.: Effect of sildenafil on hypertensive lower oesophageal sphincter. Eur J Clin Invest 2002, 32:682-685.
41. Eherer AJ, Schwetz I, Hammer HF, et al.: Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002, 50:758-764.